NDT Advance Access published online on July 21, 2006
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfl330
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 University of Florida, Department of Medicine, Gainesville, Florida, USA
* To whom correspondence should be addressed. Background. Mutations in Tamm-Horsfall protein (THP), also known as uromodulin, lead to a group of diseases known as the uromodulin storage disorders. Clinically, these diseases present with tubulo-interstitial damage, progressive renal dysfunction, hyperuricaemia, and gout. However, it remains unclear how a mutation in THP, a protein produced in the thick ascending limb, can cause hyperuricaemia when most of the uric acid transport is believed to occur in the proximal tubule. However, one study in humans suggests that uric acid could also be secreted in the distal tubule. Thus, an attractive hypothesis could be that THP would bind to uric acid in the distal tubule, and decrease its subsequent reabsorption in the distal nephron. Methods. We screened for uric acid binding to THP using four independent binding assays. Results. There was no evidence that uric acid could bind to THP. Conclusion. THP-uric acid binding does not seem to play a significant role in the regulation of urate homeostasis.
Received March 8, 2006
Accepted May 9, 2006
Brief Report
Does Tamm-Horsfall protein-uric acid binding play a significant role in urate homeostasis?
Michael S. Gersch 1 *, Yuri Y. Sautin 1, Christine M. Gersch 1, George Henderson 1, Lise Bankir 2, and Richard J. Johnson 1
2 Institut National de la Sante et de la Recherche Médicale, Unit 652, Paris, France
Michael S. Gersch, E-mail: gerscms{at}medicine.ufl.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?